S.2295 - Patient Safety and Generic Labeling Improvement Act
A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so. view all titles (2)
All Bill Titles
- Official: A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so. as introduced.
- Short: Patient Safety and Generic Labeling Improvement Act as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

U.S. Congress - S.2295 Patient Safety and Generic Labeling Improvement Act




Comments Feed
No Comments Start the Conversation!